BioPharm News

May 08, 2018
By BioPharm International Editors
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
May 07, 2018
By BioPharm International Editors
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.
May 07, 2018
By BioPharm International Editors
The data and analytics company reports on the anticipated uptake of Humira (adalimumab)‎‎ biosimilars in the EU once they are launched in 2018.
May 07, 2018
Smaller review divisions will bring experts closer to decision processes and reduce bottlenecks, FDA leaders say.
May 04, 2018
By BioPharm International Editors
GE Healthcare’s new Sefia S-2000 cell processing system allows operators to conduct multiple cell therapy manufacturing steps with one instrument.
May 03, 2018
By BioPharm International Editors
The companies will partner to develop smart connected monitoring and support solutions for injectable drugs.
May 03, 2018
By BioPharm International Editors
The company will invest EUR 325 million (US$389 million) in a new biomanufacturing facility in Ireland using single-use bioreactors.
May 03, 2018
By BioPharm International Editors
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.
May 02, 2018
Public health authorities and the biomedical research community are seeking new strategies to address global health threats.
May 01, 2018
By BioPharm International Editors
Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.
native1_300x100
lorem ipsum